Holt Capital Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.84M Buy
30,046
+1,363
+5% +$170K 0.52% 37
2025
Q4
$3.5M Buy
28,683
+3,302
+13% +$379K 0.47% 41
2025
Q3
$2.54M Buy
25,381
+1,435
+6% +$129K 0.41% 50
2025
Q2
$1.99M Sell
23,946
-2,680
-10% -$214K 0.34% 54
2025
Q1
$2.16M Buy
26,626
+3,195
+14% +$286K 0.33% 54
2024
Q4
$2.11M Buy
23,431
+3,175
+16% +$308K 0.32% 53
2024
Q3
$2M Buy
20,256
+4,780
+31% +$470K 0.3% 56
2024
Q2
$1.43M Buy
15,476
+4,605
+42% +$413K 0.31% 53
2024
Q1
$1.03M Buy
+10,871
New +$1.01M 0.17% 92

Other funds holding XBI